Revista Farmespaña Industrial Julio-Agosto 2023

diseños inteligentes, trabajadores felices: la sinergia perfecta en el sector farmacéutico El sector farmacéutico se sostiene sobre dos pilares fundamentales: la ingeniería y el mantenimiento. Estos aspectos desempeñan un papel vital al garantizar la eficiencia en la producción, la calidad de los productos y el cumplimiento de rigurosas regulaciones. JOSÉ ALBERTO GONZÁLEZ CRIADO dIRECtOR dE INGENIERÍ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j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„# !%#1/@#C'?)&/'-#./$8#'-#9)%)&'0#)"%&'-'*)2"$%8# "2#%$'12%#*','*$%#($#9$0#$-#$%,'*)2#"$*$> %'0)2#,'0'# 0$'-)A'0#$%&'%# &'0$'%#./$8#'/"./$# "2#%$#0$'-)*$"#()'0)'1$"&$8#&)$"$"#./$#%$0#-2# 1J%# *+12('%# ,2%)?-$# ,'0'# $-# ,$0%2"'-# ($# 1'"&$")1)$"&28#2#-2%#2,$0'0)2%#($#,-'"&'< I2#1$H20# ,'0'# $%&'%# -'?20$%8# $%# &$"$0# &0'> 12%# %$,'0'(2%# ,20# *2"$G)2"$%# 0J,)('%8# ($# 1'"$0'# ./$# */'-./)$0# '*&/'*)+"# %2?0$# -'# &/?$0:'8# ,/$('# %$0# 0$%/$-&'# {)"# %)&/}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ingenÍeria farmacÉutica 112 FARMESPAÑA INDUSTRIAL · JUL/AGO 23